United States · FDA National Drug Code directory
Pasatru
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61755-012_aa61176b-8199-47b9-ae53-66c4041f5ff5
- Product NDC
- 61755-012
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- garetosmab-grts
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260819
- Source listing expiry
- 20271231
Source-listed ingredients
- GARETOSMAB — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-012-01) / 5 mL in 1 VIAL, SINGLE-DOSE (61755-012-00) · 61755-012-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →